As the biopharmaceutical industry evolves rapidly, biosimilar products are reshaping the autoimmune treatment paradigm. This comprehensive eBook explores the role...
NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the...
Building on a long-term relationship with NantHealth’s Eviti Connect for Oncology, MPC commits to improving member care and managing costs...
The burden of cancer and autoimmune diseases is heavy on patients, providers, and payers in the United States. Nearly 40...
Returning guest, Dr. William Flood, Chief Medical Officer for Eviti at Nanthealth discusses the newly launched Eviti Connect for autoimmune...
We are excited about the recent launch of Eviti Connect® for autoimmune diseases, aimed at helping payers and providers realize...
Providers don’t want to delay patient care. Payers don’t want to waste money on unwarranted, ineffective autoimmune care. Both want...